Empower Clinics CEO Steven McAuley joined Proactive's Steve Darling to share news the company has signed a Letter of Intent with Las Vegas-based nuclear medicine specialist Dr Bharat Mocherla to create and operate a Dallas-based Site Management Organization.
McAuley told Proactive the end goal is to evolve this into a Contract Research Organization. The sector is booming with revenue in the neighborhood of $76 billion estimated for 2023.
The partnership will give Empower the chance to work with industry, patients, community doctors and researchers in North America to provide clinical trial management services for the pharmaceutical, biotechnology and medical device industries.
Contact Details
Proactive Investors Canada
+1 604-688-8158
na-editorial@proactiveinvestors.com
